{"transactions":[{"id":4632793,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":406,"kind":"person","name":"O'Day Daniel Patrick","position":1,"cik":"0001638643","reported_name":"O'Day Daniel Patrick","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2026-10-03T00:40:22.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":148.6265,"value":445879.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices for the transactions reported range from $148.23 to $149.13. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":566683,"source":{"system":"sec-edgar","filing":"0001638643-26-000035","document":"wk-form4_1790973619.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000163864326000035/wk-form4_1790973619.xml","form_type":"4"}},{"id":4632792,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":406,"kind":"person","name":"O'Day Daniel Patrick","position":1,"cik":"0001638643","reported_name":"O'Day Daniel Patrick","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2026-10-03T00:40:22.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":12000,"price":147.719,"value":1772628.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices for the transactions reported range from $147.21 to $148.205.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":569683,"source":{"system":"sec-edgar","filing":"0001638643-26-000035","document":"wk-form4_1790973619.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000163864326000035/wk-form4_1790973619.xml","form_type":"4"}},{"id":4625406,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controllership"}}],"security":"Restricted Stock Unit","published_at":"2026-09-23T20:17:14.000Z","date":"2026-09-22","kind":"exercise","planned":false,"acquired":false,"shares":2223,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":9022,"derivative":{"underlying":"Common Stock","underlying_shares":2223},"source":{"system":"sec-edgar","filing":"0001927648-26-000005","document":"wk-form4_1790194631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1927648/000192764826000005/wk-form4_1790194631.xml","form_type":"4"}},{"id":4625405,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2026-09-23T20:17:14.000Z","date":"2026-09-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":768,"price":152.67,"value":117250.56,"ownership":{"direct":true},"balance_after":1455,"source":{"system":"sec-edgar","filing":"0001927648-26-000005","document":"wk-form4_1790194631.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1927648/000192764826000005/wk-form4_1790194631.xml","form_type":"4"}},{"id":4625404,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14831,"kind":"person","name":"Burkhart Erin","position":1,"cik":"0001927648","reported_name":"Burkhart Erin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Controllership"}}],"security":"Common Stock","published_at":"2026-09-23T20:17:14.000Z","date":"2026-09-22","kind":"exercise","planned":false,"acquired":true,"shares":2223,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":2223,"source":{"system":"sec-edgar","filing":"0001927648-26-000005","document":"wk-form4_1790194631.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1927648/000192764826000005/wk-form4_1790194631.xml","form_type":"4"}},{"id":4619507,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-16T20:30:47.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":145.29,"value":435870.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":164096,"source":{"system":"sec-edgar","filing":"0001310204-26-000029","document":"wk-form4_1789590643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1310204/000131020426000029/wk-form4_1789590643.xml","form_type":"4"}},{"id":4619388,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-09-16T20:27:51.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":600,"price":145.29,"value":87174.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":116684,"source":{"system":"sec-edgar","filing":"0001782135-26-000033","document":"wk-form4_1789590469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782135/000178213526000033/wk-form4_1789590469.xml","form_type":"4"}},{"id":4619387,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-09-16T20:27:51.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":800,"price":144.4569,"value":115565.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices for the transactions reported range from $144.26 to $144.775.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":117284,"source":{"system":"sec-edgar","filing":"0001782135-26-000033","document":"wk-form4_1789590469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782135/000178213526000033/wk-form4_1789590469.xml","form_type":"4"}},{"id":4619386,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-09-16T20:27:51.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":1600,"price":143.6917,"value":229906.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices for the transactions reported range from $143.16 to $144.15. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":118084,"source":{"system":"sec-edgar","filing":"0001782135-26-000033","document":"wk-form4_1789590469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782135/000178213526000033/wk-form4_1789590469.xml","form_type":"4"}},{"id":4616431,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-09-11T22:30:45.000Z","date":"2026-09-10","kind":"exercise","planned":false,"acquired":false,"shares":2797,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":25054,"derivative":{"underlying":"Common Stock","underlying_shares":2797},"source":{"system":"sec-edgar","filing":"0001310204-26-000027","document":"wk-form4_1789165843.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1310204/000131020426000027/wk-form4_1789165843.xml","form_type":"4"}},{"id":4616430,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-11T22:30:45.000Z","date":"2026-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1347,"price":144.81,"value":195059.07,"ownership":{"direct":true},"balance_after":167096,"source":{"system":"sec-edgar","filing":"0001310204-26-000027","document":"wk-form4_1789165843.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1310204/000131020426000027/wk-form4_1789165843.xml","form_type":"4"}},{"id":4616429,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-11T22:30:45.000Z","date":"2026-09-10","kind":"exercise","planned":false,"acquired":true,"shares":2797,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":168443,"source":{"system":"sec-edgar","filing":"0001310204-26-000027","document":"wk-form4_1789165843.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1310204/000131020426000027/wk-form4_1789165843.xml","form_type":"4"}},{"id":4616428,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-09-11T22:29:52.000Z","date":"2026-09-10","kind":"exercise","planned":false,"acquired":false,"shares":533,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":46395,"derivative":{"underlying":"Common Stock","underlying_shares":533},"source":{"system":"sec-edgar","filing":"0001739515-26-000011","document":"wk-form4_1789165789.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1739515/000173951526000011/wk-form4_1789165789.xml","form_type":"4"}},{"id":4616427,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-11T22:29:52.000Z","date":"2026-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":263,"price":144.81,"value":38085.03,"ownership":{"direct":true},"balance_after":19522,"source":{"system":"sec-edgar","filing":"0001739515-26-000011","document":"wk-form4_1789165789.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1739515/000173951526000011/wk-form4_1789165789.xml","form_type":"4"}},{"id":4616426,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-11T22:29:52.000Z","date":"2026-09-10","kind":"exercise","planned":false,"acquired":true,"shares":533,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":19785,"source":{"system":"sec-edgar","filing":"0001739515-26-000011","document":"wk-form4_1789165789.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1739515/000173951526000011/wk-form4_1789165789.xml","form_type":"4"}},{"id":4616425,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-09-11T22:28:56.000Z","date":"2026-09-10","kind":"exercise","planned":false,"acquired":false,"shares":2797,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":25054,"derivative":{"underlying":"Common Stock","underlying_shares":2797},"source":{"system":"sec-edgar","filing":"0001782135-26-000031","document":"wk-form4_1789165734.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1782135/000178213526000031/wk-form4_1789165734.xml","form_type":"4"}},{"id":4616424,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-09-11T22:28:56.000Z","date":"2026-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1347,"price":144.81,"value":195059.07,"ownership":{"direct":true},"balance_after":119684,"source":{"system":"sec-edgar","filing":"0001782135-26-000031","document":"wk-form4_1789165734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1782135/000178213526000031/wk-form4_1789165734.xml","form_type":"4"}},{"id":4616423,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-09-11T22:28:56.000Z","date":"2026-09-10","kind":"exercise","planned":false,"acquired":true,"shares":2797,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":121031,"source":{"system":"sec-edgar","filing":"0001782135-26-000031","document":"wk-form4_1789165734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1782135/000178213526000031/wk-form4_1789165734.xml","form_type":"4"}},{"id":4616422,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Restricted Stock Unit","published_at":"2026-09-11T22:28:07.000Z","date":"2026-09-10","kind":"exercise","planned":false,"acquired":false,"shares":590,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":13405,"derivative":{"underlying":"Common Stock","underlying_shares":590},"source":{"system":"sec-edgar","filing":"0002110603-26-000013","document":"wk-form4_1789165685.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2110603/000211060326000013/wk-form4_1789165685.xml","form_type":"4"}},{"id":4616421,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Common Stock","published_at":"2026-09-11T22:28:07.000Z","date":"2026-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":285,"price":144.81,"value":41270.85,"ownership":{"direct":true},"balance_after":8759,"source":{"system":"sec-edgar","filing":"0002110603-26-000013","document":"wk-form4_1789165685.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2110603/000211060326000013/wk-form4_1789165685.xml","form_type":"4"}},{"id":4616420,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Common Stock","published_at":"2026-09-11T22:28:07.000Z","date":"2026-09-10","kind":"exercise","planned":false,"acquired":true,"shares":590,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":9044,"source":{"system":"sec-edgar","filing":"0002110603-26-000013","document":"wk-form4_1789165685.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2110603/000211060326000013/wk-form4_1789165685.xml","form_type":"4"}},{"id":4616419,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":406,"kind":"person","name":"O'Day Daniel Patrick","position":1,"cik":"0001638643","reported_name":"O'Day Daniel Patrick","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-09-11T22:27:11.000Z","date":"2026-09-10","kind":"exercise","planned":false,"acquired":false,"shares":8780,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":83300,"derivative":{"underlying":"Common Stock","underlying_shares":8780},"source":{"system":"sec-edgar","filing":"0001638643-26-000033","document":"wk-form4_1789165629.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1638643/000163864326000033/wk-form4_1789165629.xml","form_type":"4"}},{"id":4616418,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":406,"kind":"person","name":"O'Day Daniel Patrick","position":1,"cik":"0001638643","reported_name":"O'Day Daniel Patrick","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2026-09-11T22:27:11.000Z","date":"2026-09-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":4230,"price":144.81,"value":612546.3,"ownership":{"direct":true},"balance_after":581683,"source":{"system":"sec-edgar","filing":"0001638643-26-000033","document":"wk-form4_1789165629.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1638643/000163864326000033/wk-form4_1789165629.xml","form_type":"4"}},{"id":4616417,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":406,"kind":"person","name":"O'Day Daniel Patrick","position":1,"cik":"0001638643","reported_name":"O'Day Daniel Patrick","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2026-09-11T22:27:11.000Z","date":"2026-09-10","kind":"exercise","planned":false,"acquired":true,"shares":8780,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":585913,"source":{"system":"sec-edgar","filing":"0001638643-26-000033","document":"wk-form4_1789165629.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638643/000163864326000033/wk-form4_1789165629.xml","form_type":"4"}},{"id":440,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":406,"kind":"person","name":"O'Day Daniel Patrick","position":1,"cik":"0001638643","reported_name":"O'Day Daniel Patrick","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2026-09-02T20:12:46.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":5408,"price":149.3817,"value":807856.2336,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices for the transactions reported range from $148.96 to $149.94.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":577133,"source":{"system":"sec-edgar","filing":"0001638643-26-000031","document":"wk-form4_1788379963.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1638643/000163864326000031/wk-form4_1788379963.xml","form_type":"4"}},{"id":439,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":406,"kind":"person","name":"O'Day Daniel Patrick","position":1,"cik":"0001638643","reported_name":"O'Day Daniel Patrick","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2026-09-02T20:12:46.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":7992,"price":148.3636,"value":1185721.8912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices for the transactions reported range from $147.95 to $148.93. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":582541,"source":{"system":"sec-edgar","filing":"0001638643-26-000031","document":"wk-form4_1788379963.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1638643/000163864326000031/wk-form4_1788379963.xml","form_type":"4"}},{"id":438,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":406,"kind":"person","name":"O'Day Daniel Patrick","position":1,"cik":"0001638643","reported_name":"O'Day Daniel Patrick","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2026-09-02T20:12:46.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":1600,"price":147.5087,"value":236013.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices for the transactions reported range from $146.94 to $147.92.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":590533,"source":{"system":"sec-edgar","filing":"0001638643-26-000031","document":"wk-form4_1788379963.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1638643/000163864326000031/wk-form4_1788379963.xml","form_type":"4"}},{"id":305689,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":12857,"kind":"person","name":"WELTERS ANTHONY","position":1,"cik":"0001213307","reported_name":"WELTERS ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-08-27T22:44:48.000Z","date":"2026-08-26","kind":"exercise","planned":true,"acquired":false,"shares":10282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the shares subject to the option vested on each three-month anniversary measured from October 22, 2020 such that 100% of the shares subject to the option were fully vested and exercisable on October 22, 2021."}],"balance_after":5569,"derivative":{"exercise_price":61.35,"expiration_date":"2032-05-05","underlying":"Common Stock","underlying_shares":10282},"source":{"system":"sec-edgar","filing":"0001213307-26-000005","document":"wk-form4_1787870685.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/882095/000121330726000005/wk-form4_1787870685.xml","form_type":"4"}},{"id":305688,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":12857,"kind":"person","name":"WELTERS ANTHONY","position":1,"cik":"0001213307","reported_name":"WELTERS ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-08-27T22:44:48.000Z","date":"2026-08-26","kind":"exercise","planned":true,"acquired":false,"shares":7718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"100% of the shares subject to the stock option vested immediately upon the grant date of October 22, 2020."}],"balance_after":0,"derivative":{"exercise_price":60.67,"expiration_date":"2030-10-22","underlying":"Common Stock","underlying_shares":7718},"source":{"system":"sec-edgar","filing":"0001213307-26-000005","document":"wk-form4_1787870685.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000121330726000005/wk-form4_1787870685.xml","form_type":"4"}},{"id":305687,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":12857,"kind":"person","name":"WELTERS ANTHONY","position":1,"cik":"0001213307","reported_name":"WELTERS ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-27T22:44:48.000Z","date":"2026-08-26","kind":"sale","planned":true,"acquired":false,"shares":6880,"price":148.8227,"value":1023900.176,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Sale prices for the transactions reported range from $148.57 to $149.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":12894,"source":{"system":"sec-edgar","filing":"0001213307-26-000005","document":"wk-form4_1787870685.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000121330726000005/wk-form4_1787870685.xml","form_type":"4"}},{"id":305686,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":12857,"kind":"person","name":"WELTERS ANTHONY","position":1,"cik":"0001213307","reported_name":"WELTERS ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-27T22:44:48.000Z","date":"2026-08-26","kind":"sale","planned":true,"acquired":false,"shares":3402,"price":148.2353,"value":504296.4906,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices for the transactions reported range from $147.57 to $148.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":19774,"source":{"system":"sec-edgar","filing":"0001213307-26-000005","document":"wk-form4_1787870685.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000121330726000005/wk-form4_1787870685.xml","form_type":"4"}},{"id":305685,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":12857,"kind":"person","name":"WELTERS ANTHONY","position":1,"cik":"0001213307","reported_name":"WELTERS ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-27T22:44:48.000Z","date":"2026-08-26","kind":"exercise","planned":true,"acquired":true,"shares":10282,"price":61.35,"value":630800.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026."}],"balance_after":23176,"source":{"system":"sec-edgar","filing":"0001213307-26-000005","document":"wk-form4_1787870685.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000121330726000005/wk-form4_1787870685.xml","form_type":"4"}},{"id":305684,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":12857,"kind":"person","name":"WELTERS ANTHONY","position":1,"cik":"0001213307","reported_name":"WELTERS ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-27T22:44:48.000Z","date":"2026-08-26","kind":"sale","planned":true,"acquired":false,"shares":4600,"price":148.824,"value":684590.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices for the transactions reported range from $148.58 to $149.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":12894,"source":{"system":"sec-edgar","filing":"0001213307-26-000005","document":"wk-form4_1787870685.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000121330726000005/wk-form4_1787870685.xml","form_type":"4"}},{"id":305683,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":12857,"kind":"person","name":"WELTERS ANTHONY","position":1,"cik":"0001213307","reported_name":"WELTERS ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-27T22:44:48.000Z","date":"2026-08-26","kind":"sale","planned":true,"acquired":false,"shares":3118,"price":148.3106,"value":462432.4508,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices for the transactions reported range from $147.58 to $148.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":17494,"source":{"system":"sec-edgar","filing":"0001213307-26-000005","document":"wk-form4_1787870685.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000121330726000005/wk-form4_1787870685.xml","form_type":"4"}},{"id":305682,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":12857,"kind":"person","name":"WELTERS ANTHONY","position":1,"cik":"0001213307","reported_name":"WELTERS ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-27T22:44:48.000Z","date":"2026-08-26","kind":"exercise","planned":true,"acquired":true,"shares":7718,"price":60.67,"value":468251.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026."}],"balance_after":20612,"source":{"system":"sec-edgar","filing":"0001213307-26-000005","document":"wk-form4_1787870685.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000121330726000005/wk-form4_1787870685.xml","form_type":"4"}},{"id":305898,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"exercise","planned":true,"acquired":false,"shares":335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"100% of the shares subject to the stock option vested immediately upon the grant date of May 5, 2022."}],"balance_after":11395,"derivative":{"exercise_price":61.35,"expiration_date":"2032-05-05","underlying":"Common Stock","underlying_shares":335},"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":305897,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"exercise","planned":true,"acquired":false,"shares":4665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the shares subject to the option vested on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option are fully vested."}],"balance_after":0,"derivative":{"exercise_price":67.45,"expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":4665},"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":305896,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"sale","planned":true,"acquired":false,"shares":335,"price":146.26,"value":48997.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."}],"balance_after":10066,"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":305895,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"exercise","planned":true,"acquired":true,"shares":335,"price":61.35,"value":20552.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."}],"balance_after":10401,"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":305894,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"sale","planned":true,"acquired":false,"shares":26,"price":146.36,"value":3805.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."}],"balance_after":10066,"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":305893,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"exercise","planned":true,"acquired":true,"shares":26,"price":67.45,"value":1753.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."}],"balance_after":10092,"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":305892,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"sale","planned":true,"acquired":false,"shares":1658,"price":145.7286,"value":241618.0188,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices for the transactions reported range from $145.34 to $146.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":10066,"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":305891,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"exercise","planned":true,"acquired":true,"shares":1658,"price":67.45,"value":111832.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."}],"balance_after":11724,"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":305890,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"sale","planned":true,"acquired":false,"shares":1816,"price":144.9248,"value":263183.4368,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices for the transactions reported range from $144.32 to $145.31. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":10066,"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":305889,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"exercise","planned":true,"acquired":true,"shares":1816,"price":67.45,"value":122489.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."}],"balance_after":11882,"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":305888,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"sale","planned":true,"acquired":false,"shares":1165,"price":143.7543,"value":167473.7595,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices for the transactions reported range from $143.31 to $144.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":10066,"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":305887,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-21T23:22:17.000Z","date":"2026-08-20","kind":"exercise","planned":true,"acquired":true,"shares":1165,"price":67.45,"value":78579.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026."}],"balance_after":11231,"source":{"system":"sec-edgar","filing":"0001771814-26-000005","document":"wk-form4_1787354535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000177181426000005/wk-form4_1787354535.xml","form_type":"4"}},{"id":306211,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-18T23:06:08.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":138.36,"value":415080.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":165646,"source":{"system":"sec-edgar","filing":"0001310204-26-000024","document":"wk-form4_1787094366.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000024/wk-form4_1787094366.xml","form_type":"4"}},{"id":306125,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-08-18T22:54:04.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":false,"shares":1890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":69960,"derivative":{"exercise_price":72.34,"expiration_date":"2030-03-10","underlying":"Common Stock","underlying_shares":1890},"source":{"system":"sec-edgar","filing":"0001782135-26-000028","document":"wk-form4_1787093640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000028/wk-form4_1787093640.xml","form_type":"4"}},{"id":306124,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-08-18T22:54:04.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":false,"shares":23110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":66.64,"expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":23110},"source":{"system":"sec-edgar","filing":"0001782135-26-000028","document":"wk-form4_1787093640.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000028/wk-form4_1787093640.xml","form_type":"4"}},{"id":306123,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-08-18T22:54:04.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":11470,"price":138.0353,"value":1583264.891,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices for the transactions reported range from $137.75 to $138.36. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":118234,"source":{"system":"sec-edgar","filing":"0001782135-26-000028","document":"wk-form4_1787093640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000028/wk-form4_1787093640.xml","form_type":"4"}},{"id":306122,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-08-18T22:54:04.000Z","date":"2026-08-17","kind":"sale","planned":true,"acquired":false,"shares":16530,"price":137.365,"value":2270643.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices for the transactions reported range from $136.74 to $137.73. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":129704,"source":{"system":"sec-edgar","filing":"0001782135-26-000028","document":"wk-form4_1787093640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000028/wk-form4_1787093640.xml","form_type":"4"}},{"id":306121,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-08-18T22:54:04.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":true,"shares":1890,"price":72.34,"value":136722.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":146234,"source":{"system":"sec-edgar","filing":"0001782135-26-000028","document":"wk-form4_1787093640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000028/wk-form4_1787093640.xml","form_type":"4"}},{"id":306120,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-08-18T22:54:04.000Z","date":"2026-08-17","kind":"exercise","planned":true,"acquired":true,"shares":23110,"price":66.64,"value":1540050.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":144344,"source":{"system":"sec-edgar","filing":"0001782135-26-000028","document":"wk-form4_1787093640.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000028/wk-form4_1787093640.xml","form_type":"4"}},{"id":306379,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Restricted Stock Unit","published_at":"2026-08-11T20:51:01.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":false,"shares":6002,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a three-year vesting schedule.  33.33% vest on each yearly anniversary of the date of grant until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a three-year vesting schedule.  33.33% vest on each yearly anniversary of the date of grant until fully vested."}],"balance_after":13995,"derivative":{"underlying":"Common Stock","underlying_shares":6002},"source":{"system":"sec-edgar","filing":"0002110603-26-000010","document":"wk-form4_1786481458.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000211060326000010/wk-form4_1786481458.xml","form_type":"4"}},{"id":306378,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Common Stock","published_at":"2026-08-11T20:51:01.000Z","date":"2026-08-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2908,"price":133.06,"value":386938.48,"ownership":{"direct":true},"balance_after":8454,"source":{"system":"sec-edgar","filing":"0002110603-26-000010","document":"wk-form4_1786481458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000211060326000010/wk-form4_1786481458.xml","form_type":"4"}},{"id":306377,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Common Stock","published_at":"2026-08-11T20:51:01.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":true,"shares":6002,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":11362,"source":{"system":"sec-edgar","filing":"0002110603-26-000010","document":"wk-form4_1786481458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000211060326000010/wk-form4_1786481458.xml","form_type":"4"}},{"id":306672,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":406,"kind":"person","name":"O'Day Daniel Patrick","position":1,"cik":"0001638643","reported_name":"O'Day Daniel Patrick","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2026-08-04T21:40:36.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":600,"price":131.3433,"value":78805.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices for the transactions reported range from $131.21 to $131.47.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":592133,"source":{"system":"sec-edgar","filing":"0001638643-26-000028","document":"wk-form4_1785879633.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000163864326000028/wk-form4_1785879633.xml","form_type":"4"}},{"id":306671,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":406,"kind":"person","name":"O'Day Daniel Patrick","position":1,"cik":"0001638643","reported_name":"O'Day Daniel Patrick","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2026-08-04T21:40:36.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":7700,"price":130.8022,"value":1007176.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices for the transactions reported range from $130.18 to $131.17. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":592733,"source":{"system":"sec-edgar","filing":"0001638643-26-000028","document":"wk-form4_1785879633.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000163864326000028/wk-form4_1785879633.xml","form_type":"4"}},{"id":306670,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":406,"kind":"person","name":"O'Day Daniel Patrick","position":1,"cik":"0001638643","reported_name":"O'Day Daniel Patrick","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2026-08-04T21:40:36.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":6700,"price":129.6583,"value":868710.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices for the transactions reported range from $129.17 to $130.16.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":600433,"source":{"system":"sec-edgar","filing":"0001638643-26-000028","document":"wk-form4_1785879633.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000163864326000028/wk-form4_1785879633.xml","form_type":"4"}},{"id":307155,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-16T22:08:03.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":129.9256,"value":389776.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices for the transactions reported range from $129.45 to $130.08. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":168646,"source":{"system":"sec-edgar","filing":"0001310204-26-000022","document":"wk-form4_1784239680.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000022/wk-form4_1784239680.xml","form_type":"4"}},{"id":307092,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-07-16T20:54:41.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":129.9192,"value":389757.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices for the transactions reported range from $129.45 to $130.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":121234,"source":{"system":"sec-edgar","filing":"0001782135-26-000026","document":"wk-form4_1784235279.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000026/wk-form4_1784235279.xml","form_type":"4"}},{"id":307514,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":406,"kind":"person","name":"O'Day Daniel Patrick","position":1,"cik":"0001638643","reported_name":"O'Day Daniel Patrick","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2026-07-02T20:14:19.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":3100,"price":127.075,"value":393932.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices for the transactions reported range from $126.595 to $127.44. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":607133,"source":{"system":"sec-edgar","filing":"0001638643-26-000026","document":"wk-form4_1783023256.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000163864326000026/wk-form4_1783023256.xml","form_type":"4"}},{"id":307513,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":406,"kind":"person","name":"O'Day Daniel Patrick","position":1,"cik":"0001638643","reported_name":"O'Day Daniel Patrick","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2026-07-02T20:14:19.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":11900,"price":126.0897,"value":1500467.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices for the transactions reported range from $125.59 to $126.55. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":610233,"source":{"system":"sec-edgar","filing":"0001638643-26-000026","document":"wk-form4_1783023256.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000163864326000026/wk-form4_1783023256.xml","form_type":"4"}},{"id":308227,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-06-16T22:02:08.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":450,"price":125.4,"value":56430.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":124234,"source":{"system":"sec-edgar","filing":"0001782135-26-000024","document":"wk-form4_1781647325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000024/wk-form4_1781647325.xml","form_type":"4"}},{"id":308226,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-06-16T22:02:08.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":1070,"price":123.9958,"value":132675.506,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices for the transactions reported range from $123.81 to $124.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":124684,"source":{"system":"sec-edgar","filing":"0001782135-26-000024","document":"wk-form4_1781647325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000024/wk-form4_1781647325.xml","form_type":"4"}},{"id":308225,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-06-16T22:02:08.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":1480,"price":123.4166,"value":182656.568,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices for the transactions reported range from $122.79 to $123.785. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":125754,"source":{"system":"sec-edgar","filing":"0001782135-26-000024","document":"wk-form4_1781647325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000024/wk-form4_1781647325.xml","form_type":"4"}},{"id":308240,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-16T21:53:26.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":125.4,"value":376200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":171646,"source":{"system":"sec-edgar","filing":"0001310204-26-000020","document":"wk-form4_1781646803.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000020/wk-form4_1781646803.xml","form_type":"4"}},{"id":308402,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-06-11T22:35:57.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":false,"shares":533,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":46928,"derivative":{"underlying":"Common Stock","underlying_shares":533},"source":{"system":"sec-edgar","filing":"0001739515-26-000008","document":"wk-form4_1781217354.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000173951526000008/wk-form4_1781217354.xml","form_type":"4"}},{"id":308401,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-11T22:35:57.000Z","date":"2026-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":263,"price":121.48,"value":31949.24,"ownership":{"direct":true},"balance_after":19252,"source":{"system":"sec-edgar","filing":"0001739515-26-000008","document":"wk-form4_1781217354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000173951526000008/wk-form4_1781217354.xml","form_type":"4"}},{"id":308400,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14557,"kind":"person","name":"Berger Dietmar","position":1,"cik":"0001739515","reported_name":"Berger Dietmar","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-06-11T22:35:57.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":true,"shares":533,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":19515,"source":{"system":"sec-edgar","filing":"0001739515-26-000008","document":"wk-form4_1781217354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000173951526000008/wk-form4_1781217354.xml","form_type":"4"}},{"id":308341,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Restricted Stock Unit","published_at":"2026-06-11T22:34:06.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":false,"shares":589,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":19997,"derivative":{"underlying":"Common Stock","underlying_shares":589},"source":{"system":"sec-edgar","filing":"0002110603-26-000008","document":"wk-form4_1781217244.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000211060326000008/wk-form4_1781217244.xml","form_type":"4"}},{"id":308340,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Common Stock","published_at":"2026-06-11T22:34:06.000Z","date":"2026-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":283,"price":121.48,"value":34378.84,"ownership":{"direct":true},"balance_after":5360,"source":{"system":"sec-edgar","filing":"0002110603-26-000008","document":"wk-form4_1781217244.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000211060326000008/wk-form4_1781217244.xml","form_type":"4"}},{"id":308339,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14319,"kind":"person","name":"Cain Wettan Keeley M","position":1,"cik":"0002110603","reported_name":"Cain Wettan Keeley M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP Gen Counsel,  Legal & Comp"}}],"security":"Common Stock","published_at":"2026-06-11T22:34:06.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":true,"shares":589,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":5643,"source":{"system":"sec-edgar","filing":"0002110603-26-000008","document":"wk-form4_1781217244.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000211060326000008/wk-form4_1781217244.xml","form_type":"4"}},{"id":308408,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-06-11T22:32:47.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":false,"shares":2796,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":27851,"derivative":{"underlying":"Common Stock","underlying_shares":2796},"source":{"system":"sec-edgar","filing":"0001310204-26-000018","document":"wk-form4_1781217163.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000018/wk-form4_1781217163.xml","form_type":"4"}},{"id":308407,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-11T22:32:47.000Z","date":"2026-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1341,"price":121.48,"value":162904.68,"ownership":{"direct":true},"balance_after":174646,"source":{"system":"sec-edgar","filing":"0001310204-26-000018","document":"wk-form4_1781217163.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000018/wk-form4_1781217163.xml","form_type":"4"}},{"id":308406,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-11T22:32:47.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":true,"shares":2796,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":175987,"source":{"system":"sec-edgar","filing":"0001310204-26-000018","document":"wk-form4_1781217163.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000018/wk-form4_1781217163.xml","form_type":"4"}},{"id":308344,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-06-11T22:31:10.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":false,"shares":2796,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a 4-year vesting schedule.  25% vest on the first anniversary of the grant date.  The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":27851,"derivative":{"underlying":"Common Stock","underlying_shares":2796},"source":{"system":"sec-edgar","filing":"0001782135-26-000022","document":"wk-form4_1781217068.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000022/wk-form4_1781217068.xml","form_type":"4"}},{"id":308343,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-06-11T22:31:10.000Z","date":"2026-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":1341,"price":121.48,"value":162904.68,"ownership":{"direct":true},"balance_after":127234,"source":{"system":"sec-edgar","filing":"0001782135-26-000022","document":"wk-form4_1781217068.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000022/wk-form4_1781217068.xml","form_type":"4"}},{"id":308342,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-06-11T22:31:10.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":true,"shares":2796,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":128575,"source":{"system":"sec-edgar","filing":"0001782135-26-000022","document":"wk-form4_1781217068.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000022/wk-form4_1781217068.xml","form_type":"4"}},{"id":308405,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":406,"kind":"person","name":"O'Day Daniel Patrick","position":1,"cik":"0001638643","reported_name":"O'Day Daniel Patrick","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-06-11T22:29:51.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":false,"shares":8779,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":92080,"derivative":{"underlying":"Common Stock","underlying_shares":8779},"source":{"system":"sec-edgar","filing":"0001638643-26-000024","document":"wk-form4_1781216988.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000163864326000024/wk-form4_1781216988.xml","form_type":"4"}},{"id":308404,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":406,"kind":"person","name":"O'Day Daniel Patrick","position":1,"cik":"0001638643","reported_name":"O'Day Daniel Patrick","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2026-06-11T22:29:51.000Z","date":"2026-06-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":4213,"price":121.48,"value":511795.24,"ownership":{"direct":true},"balance_after":622133,"source":{"system":"sec-edgar","filing":"0001638643-26-000024","document":"wk-form4_1781216988.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000163864326000024/wk-form4_1781216988.xml","form_type":"4"}},{"id":308403,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":406,"kind":"person","name":"O'Day Daniel Patrick","position":1,"cik":"0001638643","reported_name":"O'Day Daniel Patrick","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2026-06-11T22:29:51.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":true,"shares":8779,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."}],"balance_after":626346,"source":{"system":"sec-edgar","filing":"0001638643-26-000024","document":"wk-form4_1781216988.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000163864326000024/wk-form4_1781216988.xml","form_type":"4"}},{"id":308843,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":406,"kind":"person","name":"O'Day Daniel Patrick","position":1,"cik":"0001638643","reported_name":"O'Day Daniel Patrick","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2026-06-02T22:04:05.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":1038,"price":132.9678,"value":138020.5764,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices for the transactions reported range from $132.71 to $133.295. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":617567,"source":{"system":"sec-edgar","filing":"0001638643-26-000022","document":"wk-form4_1780437841.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000163864326000022/wk-form4_1780437841.xml","form_type":"4"}},{"id":308842,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":406,"kind":"person","name":"O'Day Daniel Patrick","position":1,"cik":"0001638643","reported_name":"O'Day Daniel Patrick","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2026-06-02T22:04:05.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":3062,"price":132.2151,"value":404842.6362,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices for the transactions reported range from $131.71 to $132.70. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":618605,"source":{"system":"sec-edgar","filing":"0001638643-26-000022","document":"wk-form4_1780437841.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000163864326000022/wk-form4_1780437841.xml","form_type":"4"}},{"id":308841,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":406,"kind":"person","name":"O'Day Daniel Patrick","position":1,"cik":"0001638643","reported_name":"O'Day Daniel Patrick","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2026-06-02T22:04:05.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":10900,"price":131.0994,"value":1428983.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices for the transactions reported range from $130.66 to $131.64. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":621667,"source":{"system":"sec-edgar","filing":"0001638643-26-000022","document":"wk-form4_1780437841.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000163864326000022/wk-form4_1780437841.xml","form_type":"4"}},{"id":309553,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14295,"kind":"person","name":"Dickinson Andrew D","position":1,"cik":"0001310204","reported_name":"Dickinson Andrew D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-18T21:50:30.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":132.27,"value":396810.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024."}],"balance_after":173191,"source":{"system":"sec-edgar","filing":"0001310204-26-000016","document":"wk-form4_1779141028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000131020426000016/wk-form4_1779141028.xml","form_type":"4"}},{"id":309473,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-05-18T21:45:39.000Z","date":"2026-05-15","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested."}],"balance_after":23110,"derivative":{"exercise_price":66.64,"expiration_date":"2029-07-24","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001782135-26-000016","document":"wk-form4_1779140737.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000016/wk-form4_1779140737.xml","form_type":"4"}},{"id":309472,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-05-18T21:45:39.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":700,"price":132.7514,"value":92925.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Sale prices for the transactions reported range from $132.74 to $132.78. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":125779,"source":{"system":"sec-edgar","filing":"0001782135-26-000016","document":"wk-form4_1779140737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000016/wk-form4_1779140737.xml","form_type":"4"}},{"id":309471,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-05-18T21:45:39.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":8374,"price":132.2324,"value":1107314.1176,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices for the transactions reported range from $131.71 to $132.55. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":126479,"source":{"system":"sec-edgar","filing":"0001782135-26-000016","document":"wk-form4_1779140737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000016/wk-form4_1779140737.xml","form_type":"4"}},{"id":309470,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-05-18T21:45:39.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":11177,"price":131.1917,"value":1466329.6309,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices for the transactions reported range from $130.67 to $131.505. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":134853,"source":{"system":"sec-edgar","filing":"0001782135-26-000016","document":"wk-form4_1779140737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000016/wk-form4_1779140737.xml","form_type":"4"}},{"id":309469,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-05-18T21:45:39.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":7749,"price":130.2915,"value":1009628.8335,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices for the transactions reported range from $129.66 to $130.63. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request."}],"balance_after":146030,"source":{"system":"sec-edgar","filing":"0001782135-26-000016","document":"wk-form4_1779140737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000016/wk-form4_1779140737.xml","form_type":"4"}},{"id":309468,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14289,"kind":"person","name":"Mercier Johanna","position":1,"cik":"0001782135","reported_name":"Mercier Johanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Comm & Corp Aff Officer"}}],"security":"Common Stock","published_at":"2026-05-18T21:45:39.000Z","date":"2026-05-15","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":66.64,"value":1666000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025."}],"balance_after":153779,"source":{"system":"sec-edgar","filing":"0001782135-26-000016","document":"wk-form4_1779140737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000178213526000016/wk-form4_1779140737.xml","form_type":"4"}},{"id":310146,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-05-04T20:40:28.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":4884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the stock option vested immediately upon the grant date of April 30, 2026."}],"balance_after":4884,"derivative":{"exercise_price":130.84,"expiration_date":"2036-04-30","underlying":"Common Stock","underlying_shares":4884},"source":{"system":"sec-edgar","filing":"0000882095-26-000010","document":"wk-form4_1777927225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000010/wk-form4_1777927225.xml","form_type":"4"}},{"id":310145,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14252,"kind":"person","name":"Bluestone Jeffrey","position":1,"cik":"0001771814","reported_name":"Bluestone Jeffrey","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T20:40:28.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":1146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents 1,146 restricted stock units (\"RSUs\") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan.  Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of April 30, 2026."}],"balance_after":10066,"source":{"system":"sec-edgar","filing":"0000882095-26-000010","document":"wk-form4_1777927225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000010/wk-form4_1777927225.xml","form_type":"4"}},{"id":310133,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-05-04T20:36:45.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":4884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the stock option vested immediately upon the grant date of April 30, 2026."}],"balance_after":4884,"derivative":{"exercise_price":130.84,"expiration_date":"2036-04-30","underlying":"Common Stock","underlying_shares":4884},"source":{"system":"sec-edgar","filing":"0001183680-26-000002","document":"wk-form4_1777927002.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000118368026000002/wk-form4_1777927002.xml","form_type":"4"}},{"id":310132,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14726,"kind":"person","name":"BARTON JACQUELINE K","position":1,"cik":"0001183680","reported_name":"BARTON JACQUELINE K","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T20:36:45.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":1146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents 1,146 restricted stock units (\"RSUs\") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan.  Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of April 30, 2026."}],"balance_after":27202,"source":{"system":"sec-edgar","filing":"0001183680-26-000002","document":"wk-form4_1777927002.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000118368026000002/wk-form4_1777927002.xml","form_type":"4"}},{"id":310093,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14722,"kind":"person","name":"Horning Sandra","position":1,"cik":"0001638709","reported_name":"Horning Sandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-05-04T20:31:49.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":4884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the stock option vested immediately upon the grant date of April 30, 2026."}],"balance_after":4884,"derivative":{"exercise_price":130.84,"expiration_date":"2036-04-30","underlying":"Common Stock","underlying_shares":4884},"source":{"system":"sec-edgar","filing":"0001638709-26-000002","document":"wk-form4_1777926706.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000163870926000002/wk-form4_1777926706.xml","form_type":"4"}},{"id":310092,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":14722,"kind":"person","name":"Horning Sandra","position":1,"cik":"0001638709","reported_name":"Horning Sandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T20:31:49.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":1146,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents 1,146 restricted stock units (\"RSUs\") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan.  Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of April 30, 2026."}],"balance_after":6293,"source":{"system":"sec-edgar","filing":"0001638709-26-000002","document":"wk-form4_1777926706.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000163870926000002/wk-form4_1777926706.xml","form_type":"4"}},{"id":310131,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":893,"kind":"person","name":"LOVE TED W","position":1,"cik":"0001188919","reported_name":"LOVE TED W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2026-05-04T20:28:34.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":4884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the stock option vested immediately upon the grant date of April 30, 2026."}],"balance_after":4884,"derivative":{"exercise_price":130.84,"expiration_date":"2036-04-30","underlying":"Common Stock","underlying_shares":4884},"source":{"system":"sec-edgar","filing":"0001188919-26-000004","document":"wk-form4_1777926511.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000118891926000004/wk-form4_1777926511.xml","form_type":"4"}}],"next_cursor":"2026-05-04T20:28:34.000000Z,310131"}